Supernus Pharmaceuticals (SUPN) Convertible Debt (2013 - 2022)
Supernus Pharmaceuticals (SUPN) reported Convertible Debt of $400.38 million for Q1 2022, up 9.4% from $366.04 million a year earlier and up 5.6% from the prior quarter.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Convertible Debt (2013 - 2022) Analysis & Trends
At the end of FY2021, Supernus Pharmaceuticals posted Convertible Debt of $379.25 million, up 4.8% from FY2020.
- Convertible Debt has increased for three consecutive years, with a five-year compound annual growth rate of 146.5% (FY2016 to FY2021).
- By year, Convertible Debt came in at $361.75 million in FY2020 (+4.8%), $345.17 million in FY2019 (+4.8%) and $329.46 million in FY2018.
- The Q1 2022 figure ranks as the highest quarterly Convertible Debt in data going back to Q2 2013.
- Year over year, Convertible Debt has now increased in each of the last 13 quarters, with growth averaging 5.4% over the last eight quarters.
- The high point for year-over-year Convertible Debt in five years was Q1 2022 (growth of 9.4%); the low point was Q2 2017 (a decline of 74.2%).
- Per Business Quant data, the three quarters before Q1 2022 came in at $379.25 million (Q4 2021), $374.79 million (Q3 2021) and $370.38 million (Q2 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Supernus Pharmaceuticals | 2.59 Bn | 1.25 Bn | 185.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 400.38 Mn |
| Dec 31, 2021 | 379.25 Mn |
| Sep 30, 2021 | 374.79 Mn |
| Jun 30, 2021 | 370.38 Mn |
| Mar 31, 2021 | 366.04 Mn |
| Dec 31, 2020 | 361.75 Mn |
| Sep 30, 2020 | 357.52 Mn |
| Jun 30, 2020 | 353.35 Mn |
| Mar 31, 2020 | 349.23 Mn |
| Dec 31, 2019 | 345.17 Mn |
| Sep 30, 2019 | 341.16 Mn |
| Jun 30, 2019 | 337.21 Mn |
| Mar 31, 2019 | 333.31 Mn |
| Dec 31, 2018 | 329.46 Mn |
| Sep 30, 2018 | 325.67 Mn |
| Jun 30, 2018 | 321.92 Mn |
| Mar 31, 2018 | 318.23 Mn |
| Jun 30, 2017 | 1.47 Mn |
| Mar 31, 2017 | 3.31 Mn |
| Dec 31, 2016 | 4.17 Mn |
API Access
Supernus Pharmaceuticals Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();